The benefits manifest at multiple levels, including the immune cell composition (e.g., preservation of naïve T cells and normalization of CD4/CD8 ratio), the inflammatory milieu (reduced TNF-α and CRP), and functional outcomes (enhanced vaccine responsiveness and lower infection risk) (Table 1 and Table 2). The gene discussed is TNF; the disease is infection.